Global Neisseria meningitidis Infections Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Neisseria meningitidis Infections Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Neisseria meningitidis Infections Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Neisseria meningitidis Infections Drug by Country/Region, 2017, 2022 & 2028

2.2 Neisseria meningitidis Infections Drug Segment by Type

2.2.1 MGBBP-3

2.2.2 NCL-195

2.2.3 TP-10

2.2.4 Others

2.3 Neisseria meningitidis Infections Drug Sales by Type

2.3.1 Global Neisseria meningitidis Infections Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Neisseria meningitidis Infections Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Neisseria meningitidis Infections Drug Sale Price by Type (2017-2022)

2.4 Neisseria meningitidis Infections Drug Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Neisseria meningitidis Infections Drug Sales by Application

2.5.1 Global Neisseria meningitidis Infections Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Neisseria meningitidis Infections Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Neisseria meningitidis Infections Drug Sale Price by Application (2017-2022)

3 Global Neisseria meningitidis Infections Drug by Company

3.1 Global Neisseria meningitidis Infections Drug Breakdown Data by Company

3.1.1 Global Neisseria meningitidis Infections Drug Annual Sales by Company (2020-2022)

3.1.2 Global Neisseria meningitidis Infections Drug Sales Market Share by Company (2020-2022)

3.2 Global Neisseria meningitidis Infections Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Neisseria meningitidis Infections Drug Revenue by Company (2020-2022)

3.2.2 Global Neisseria meningitidis Infections Drug Revenue Market Share by Company (2020-2022)

3.3 Global Neisseria meningitidis Infections Drug Sale Price by Company

3.4 Key Manufacturers Neisseria meningitidis Infections Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Neisseria meningitidis Infections Drug Product Location Distribution

3.4.2 Players Neisseria meningitidis Infections Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Neisseria meningitidis Infections Drug by Geographic Region

4.1 World Historic Neisseria meningitidis Infections Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Neisseria meningitidis Infections Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Neisseria meningitidis Infections Drug Annual Revenue by Geographic Region

4.2 World Historic Neisseria meningitidis Infections Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Neisseria meningitidis Infections Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Neisseria meningitidis Infections Drug Annual Revenue by Country/Region

4.3 Americas Neisseria meningitidis Infections Drug Sales Growth

4.4 APAC Neisseria meningitidis Infections Drug Sales Growth

4.5 Europe Neisseria meningitidis Infections Drug Sales Growth

4.6 Middle East & Africa Neisseria meningitidis Infections Drug Sales Growth

5 Americas

5.1 Americas Neisseria meningitidis Infections Drug Sales by Country

5.1.1 Americas Neisseria meningitidis Infections Drug Sales by Country (2017-2022)

5.1.2 Americas Neisseria meningitidis Infections Drug Revenue by Country (2017-2022)

5.2 Americas Neisseria meningitidis Infections Drug Sales by Type

5.3 Americas Neisseria meningitidis Infections Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Neisseria meningitidis Infections Drug Sales by Region

6.1.1 APAC Neisseria meningitidis Infections Drug Sales by Region (2017-2022)

6.1.2 APAC Neisseria meningitidis Infections Drug Revenue by Region (2017-2022)

6.2 APAC Neisseria meningitidis Infections Drug Sales by Type

6.3 APAC Neisseria meningitidis Infections Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Neisseria meningitidis Infections Drug by Country

7.1.1 Europe Neisseria meningitidis Infections Drug Sales by Country (2017-2022)

7.1.2 Europe Neisseria meningitidis Infections Drug Revenue by Country (2017-2022)

7.2 Europe Neisseria meningitidis Infections Drug Sales by Type

7.3 Europe Neisseria meningitidis Infections Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Neisseria meningitidis Infections Drug by Country

8.1.1 Middle East & Africa Neisseria meningitidis Infections Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Neisseria meningitidis Infections Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Neisseria meningitidis Infections Drug Sales by Type

8.3 Middle East & Africa Neisseria meningitidis Infections Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Neisseria meningitidis Infections Drug

10.3 Manufacturing Process Analysis of Neisseria meningitidis Infections Drug

10.4 Industry Chain Structure of Neisseria meningitidis Infections Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Neisseria meningitidis Infections Drug Distributors

11.3 Neisseria meningitidis Infections Drug Customer

12 World Forecast Review for Neisseria meningitidis Infections Drug by Geographic Region

12.1 Global Neisseria meningitidis Infections Drug Market Size Forecast by Region

12.1.1 Global Neisseria meningitidis Infections Drug Forecast by Region (2023-2028)

12.1.2 Global Neisseria meningitidis Infections Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Neisseria meningitidis Infections Drug Forecast by Type

12.7 Global Neisseria meningitidis Infections Drug Forecast by Application

13 Key Players Analysis

13.1 Beijing Minhai Biotechnology Co Ltd

13.1.1 Beijing Minhai Biotechnology Co Ltd Company Information

13.1.2 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Product Offered

13.1.3 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Beijing Minhai Biotechnology Co Ltd Main Business Overview

13.1.5 Beijing Minhai Biotechnology Co Ltd Latest Developments

13.2 Biological E Ltd

13.2.1 Biological E Ltd Company Information

13.2.2 Biological E Ltd Neisseria meningitidis Infections Drug Product Offered

13.2.3 Biological E Ltd Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Biological E Ltd Main Business Overview

13.2.5 Biological E Ltd Latest Developments

13.3 China National Pharmaceutical Group Corp

13.3.1 China National Pharmaceutical Group Corp Company Information

13.3.2 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Product Offered

13.3.3 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 China National Pharmaceutical Group Corp Main Business Overview

13.3.5 China National Pharmaceutical Group Corp Latest Developments

13.4 GlaxoSmithKline Plc

13.4.1 GlaxoSmithKline Plc Company Information

13.4.2 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Product Offered

13.4.3 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 GlaxoSmithKline Plc Main Business Overview

13.4.5 GlaxoSmithKline Plc Latest Developments

13.5 Griffith University

13.5.1 Griffith University Company Information

13.5.2 Griffith University Neisseria meningitidis Infections Drug Product Offered

13.5.3 Griffith University Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Griffith University Main Business Overview

13.5.5 Griffith University Latest Developments

13.6 ImmunoBiology Ltd

13.6.1 ImmunoBiology Ltd Company Information

13.6.2 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Product Offered

13.6.3 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 ImmunoBiology Ltd Main Business Overview

13.6.5 ImmunoBiology Ltd Latest Developments

13.7 JN-International Medical Corp

13.7.1 JN-International Medical Corp Company Information

13.7.2 JN-International Medical Corp Neisseria meningitidis Infections Drug Product Offered

13.7.3 JN-International Medical Corp Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 JN-International Medical Corp Main Business Overview

13.7.5 JN-International Medical Corp Latest Developments

13.8 MGB Biopharma Ltd

13.8.1 MGB Biopharma Ltd Company Information

13.8.2 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Product Offered

13.8.3 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 MGB Biopharma Ltd Main Business Overview

13.8.5 MGB Biopharma Ltd Latest Developments

13.9 Panacea Biotec Ltd

13.9.1 Panacea Biotec Ltd Company Information

13.9.2 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Product Offered

13.9.3 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Panacea Biotec Ltd Main Business Overview

13.9.5 Panacea Biotec Ltd Latest Developments

13.10 Pfizer Inc

13.10.1 Pfizer Inc Company Information

13.10.2 Pfizer Inc Neisseria meningitidis Infections Drug Product Offered

13.10.3 Pfizer Inc Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Pfizer Inc Main Business Overview

13.10.5 Pfizer Inc Latest Developments

13.11 Sanofi Pasteur SA

13.11.1 Sanofi Pasteur SA Company Information

13.11.2 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Product Offered

13.11.3 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Sanofi Pasteur SA Main Business Overview

13.11.5 Sanofi Pasteur SA Latest Developments

13.12 Serum Institute of India Ltd

13.12.1 Serum Institute of India Ltd Company Information

13.12.2 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Product Offered

13.12.3 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Serum Institute of India Ltd Main Business Overview

13.12.5 Serum Institute of India Ltd Latest Developments

13.13 Wellstat Vaccines LLC

13.13.1 Wellstat Vaccines LLC Company Information

13.13.2 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Product Offered

13.13.3 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Wellstat Vaccines LLC Main Business Overview

13.13.5 Wellstat Vaccines LLC Latest Developments

14 Research Findings and Conclusion

Table 1. Neisseria meningitidis Infections Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Neisseria meningitidis Infections Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of MGBBP-3

Table 4. Major Players of NCL-195

Table 5. Major Players of TP-10

Table 6. Major Players of Others

Table 7. Global Neisseria meningitidis Infections Drug Sales by Type (2017-2022) & (K Pcs)

Table 8. Global Neisseria meningitidis Infections Drug Sales Market Share by Type (2017-2022)

Table 9. Global Neisseria meningitidis Infections Drug Revenue by Type (2017-2022) & ($ million)

Table 10. Global Neisseria meningitidis Infections Drug Revenue Market Share by Type (2017-2022)

Table 11. Global Neisseria meningitidis Infections Drug Sale Price by Type (2017-2022) & (USD/Pcs)

Table 12. Global Neisseria meningitidis Infections Drug Sales by Application (2017-2022) & (K Pcs)

Table 13. Global Neisseria meningitidis Infections Drug Sales Market Share by Application (2017-2022)

Table 14. Global Neisseria meningitidis Infections Drug Revenue by Application (2017-2022)

Table 15. Global Neisseria meningitidis Infections Drug Revenue Market Share by Application (2017-2022)

Table 16. Global Neisseria meningitidis Infections Drug Sale Price by Application (2017-2022) & (USD/Pcs)

Table 17. Global Neisseria meningitidis Infections Drug Sales by Company (2020-2022) & (K Pcs)

Table 18. Global Neisseria meningitidis Infections Drug Sales Market Share by Company (2020-2022)

Table 19. Global Neisseria meningitidis Infections Drug Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Neisseria meningitidis Infections Drug Revenue Market Share by Company (2020-2022)

Table 21. Global Neisseria meningitidis Infections Drug Sale Price by Company (2020-2022) & (USD/Pcs)

Table 22. Key Manufacturers Neisseria meningitidis Infections Drug Producing Area Distribution and Sales Area

Table 23. Players Neisseria meningitidis Infections Drug Products Offered

Table 24. Neisseria meningitidis Infections Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Neisseria meningitidis Infections Drug Sales by Geographic Region (2017-2022) & (K Pcs)

Table 28. Global Neisseria meningitidis Infections Drug Sales Market Share Geographic Region (2017-2022)

Table 29. Global Neisseria meningitidis Infections Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Neisseria meningitidis Infections Drug Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Neisseria meningitidis Infections Drug Sales by Country/Region (2017-2022) & (K Pcs)

Table 32. Global Neisseria meningitidis Infections Drug Sales Market Share by Country/Region (2017-2022)

Table 33. Global Neisseria meningitidis Infections Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Neisseria meningitidis Infections Drug Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Neisseria meningitidis Infections Drug Sales by Country (2017-2022) & (K Pcs)

Table 36. Americas Neisseria meningitidis Infections Drug Sales Market Share by Country (2017-2022)

Table 37. Americas Neisseria meningitidis Infections Drug Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Neisseria meningitidis Infections Drug Revenue Market Share by Country (2017-2022)

Table 39. Americas Neisseria meningitidis Infections Drug Sales by Type (2017-2022) & (K Pcs)

Table 40. Americas Neisseria meningitidis Infections Drug Sales Market Share by Type (2017-2022)

Table 41. Americas Neisseria meningitidis Infections Drug Sales by Application (2017-2022) & (K Pcs)

Table 42. Americas Neisseria meningitidis Infections Drug Sales Market Share by Application (2017-2022)

Table 43. APAC Neisseria meningitidis Infections Drug Sales by Region (2017-2022) & (K Pcs)

Table 44. APAC Neisseria meningitidis Infections Drug Sales Market Share by Region (2017-2022)

Table 45. APAC Neisseria meningitidis Infections Drug Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Neisseria meningitidis Infections Drug Revenue Market Share by Region (2017-2022)

Table 47. APAC Neisseria meningitidis Infections Drug Sales by Type (2017-2022) & (K Pcs)

Table 48. APAC Neisseria meningitidis Infections Drug Sales Market Share by Type (2017-2022)

Table 49. APAC Neisseria meningitidis Infections Drug Sales by Application (2017-2022) & (K Pcs)

Table 50. APAC Neisseria meningitidis Infections Drug Sales Market Share by Application (2017-2022)

Table 51. Europe Neisseria meningitidis Infections Drug Sales by Country (2017-2022) & (K Pcs)

Table 52. Europe Neisseria meningitidis Infections Drug Sales Market Share by Country (2017-2022)

Table 53. Europe Neisseria meningitidis Infections Drug Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Neisseria meningitidis Infections Drug Revenue Market Share by Country (2017-2022)

Table 55. Europe Neisseria meningitidis Infections Drug Sales by Type (2017-2022) & (K Pcs)

Table 56. Europe Neisseria meningitidis Infections Drug Sales Market Share by Type (2017-2022)

Table 57. Europe Neisseria meningitidis Infections Drug Sales by Application (2017-2022) & (K Pcs)

Table 58. Europe Neisseria meningitidis Infections Drug Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Neisseria meningitidis Infections Drug Sales by Country (2017-2022) & (K Pcs)

Table 60. Middle East & Africa Neisseria meningitidis Infections Drug Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Neisseria meningitidis Infections Drug Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Neisseria meningitidis Infections Drug Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Neisseria meningitidis Infections Drug Sales by Type (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Neisseria meningitidis Infections Drug Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Neisseria meningitidis Infections Drug Sales by Application (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Neisseria meningitidis Infections Drug Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Neisseria meningitidis Infections Drug

Table 68. Key Market Challenges & Risks of Neisseria meningitidis Infections Drug

Table 69. Key Industry Trends of Neisseria meningitidis Infections Drug

Table 70. Neisseria meningitidis Infections Drug Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Neisseria meningitidis Infections Drug Distributors List

Table 73. Neisseria meningitidis Infections Drug Customer List

Table 74. Global Neisseria meningitidis Infections Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 75. Global Neisseria meningitidis Infections Drug Sales Market Forecast by Region

Table 76. Global Neisseria meningitidis Infections Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Neisseria meningitidis Infections Drug Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Neisseria meningitidis Infections Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 79. Americas Neisseria meningitidis Infections Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Neisseria meningitidis Infections Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 81. APAC Neisseria meningitidis Infections Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Neisseria meningitidis Infections Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Europe Neisseria meningitidis Infections Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Neisseria meningitidis Infections Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Middle East & Africa Neisseria meningitidis Infections Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Neisseria meningitidis Infections Drug Sales Forecast by Type (2023-2028) & (K Pcs)

Table 87. Global Neisseria meningitidis Infections Drug Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Neisseria meningitidis Infections Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Neisseria meningitidis Infections Drug Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Neisseria meningitidis Infections Drug Sales Forecast by Application (2023-2028) & (K Pcs)

Table 91. Global Neisseria meningitidis Infections Drug Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Neisseria meningitidis Infections Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Neisseria meningitidis Infections Drug Revenue Market Share Forecast by Application (2023-2028)

Table 94. Beijing Minhai Biotechnology Co Ltd Basic Information, Neisseria meningitidis Infections Drug Manufacturing Base, Sales Area and Its Competitors

Table 95. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Product Offered

Table 96. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 97. Beijing Minhai Biotechnology Co Ltd Main Business

Table 98. Beijing Minhai Biotechnology Co Ltd Latest Developments

Table 99. Biological E Ltd Basic Information, Neisseria meningitidis Infections Drug Manufacturing Base, Sales Area and Its Competitors

Table 100. Biological E Ltd Neisseria meningitidis Infections Drug Product Offered

Table 101. Biological E Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 102. Biological E Ltd Main Business

Table 103. Biological E Ltd Latest Developments

Table 104. China National Pharmaceutical Group Corp Basic Information, Neisseria meningitidis Infections Drug Manufacturing Base, Sales Area and Its Competitors

Table 105. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Product Offered

Table 106. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 107. China National Pharmaceutical Group Corp Main Business

Table 108. China National Pharmaceutical Group Corp Latest Developments

Table 109. GlaxoSmithKline Plc Basic Information, Neisseria meningitidis Infections Drug Manufacturing Base, Sales Area and Its Competitors

Table 110. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Product Offered

Table 111. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 112. GlaxoSmithKline Plc Main Business

Table 113. GlaxoSmithKline Plc Latest Developments

Table 114. Griffith University Basic Information, Neisseria meningitidis Infections Drug Manufacturing Base, Sales Area and Its Competitors

Table 115. Griffith University Neisseria meningitidis Infections Drug Product Offered

Table 116. Griffith University Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 117. Griffith University Main Business

Table 118. Griffith University Latest Developments

Table 119. ImmunoBiology Ltd Basic Information, Neisseria meningitidis Infections Drug Manufacturing Base, Sales Area and Its Competitors

Table 120. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Product Offered

Table 121. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 122. ImmunoBiology Ltd Main Business

Table 123. ImmunoBiology Ltd Latest Developments

Table 124. JN-International Medical Corp Basic Information, Neisseria meningitidis Infections Drug Manufacturing Base, Sales Area and Its Competitors

Table 125. JN-International Medical Corp Neisseria meningitidis Infections Drug Product Offered

Table 126. JN-International Medical Corp Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 127. JN-International Medical Corp Main Business

Table 128. JN-International Medical Corp Latest Developments

Table 129. MGB Biopharma Ltd Basic Information, Neisseria meningitidis Infections Drug Manufacturing Base, Sales Area and Its Competitors

Table 130. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Product Offered

Table 131. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 132. MGB Biopharma Ltd Main Business

Table 133. MGB Biopharma Ltd Latest Developments

Table 134. Panacea Biotec Ltd Basic Information, Neisseria meningitidis Infections Drug Manufacturing Base, Sales Area and Its Competitors

Table 135. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Product Offered

Table 136. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 137. Panacea Biotec Ltd Main Business

Table 138. Panacea Biotec Ltd Latest Developments

Table 139. Pfizer Inc Basic Information, Neisseria meningitidis Infections Drug Manufacturing Base, Sales Area and Its Competitors

Table 140. Pfizer Inc Neisseria meningitidis Infections Drug Product Offered

Table 141. Pfizer Inc Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 142. Pfizer Inc Main Business

Table 143. Pfizer Inc Latest Developments

Table 144. Sanofi Pasteur SA Basic Information, Neisseria meningitidis Infections Drug Manufacturing Base, Sales Area and Its Competitors

Table 145. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Product Offered

Table 146. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 147. Sanofi Pasteur SA Main Business

Table 148. Sanofi Pasteur SA Latest Developments

Table 149. Serum Institute of India Ltd Basic Information, Neisseria meningitidis Infections Drug Manufacturing Base, Sales Area and Its Competitors

Table 150. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Product Offered

Table 151. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 152. Serum Institute of India Ltd Main Business

Table 153. Serum Institute of India Ltd Latest Developments

Table 154. Wellstat Vaccines LLC Basic Information, Neisseria meningitidis Infections Drug Manufacturing Base, Sales Area and Its Competitors

Table 155. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Product Offered

Table 156. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 157. Wellstat Vaccines LLC Main Business

Table 158. Wellstat Vaccines LLC Latest Developments

List of Figures

Figure 1. Picture of Neisseria meningitidis Infections Drug

Figure 2. Neisseria meningitidis Infections Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Neisseria meningitidis Infections Drug Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Neisseria meningitidis Infections Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Neisseria meningitidis Infections Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of MGBBP-3

Figure 10. Product Picture of NCL-195

Figure 11. Product Picture of TP-10

Figure 12. Product Picture of Others

Figure 13. Global Neisseria meningitidis Infections Drug Sales Market Share by Type in 2021

Figure 14. Global Neisseria meningitidis Infections Drug Revenue Market Share by Type (2017-2022)

Figure 15. Neisseria meningitidis Infections Drug Consumed in Hospital

Figure 16. Global Neisseria meningitidis Infections Drug Market: Hospital (2017-2022) & (K Pcs)

Figure 17. Neisseria meningitidis Infections Drug Consumed in Clinic

Figure 18. Global Neisseria meningitidis Infections Drug Market: Clinic (2017-2022) & (K Pcs)

Figure 19. Neisseria meningitidis Infections Drug Consumed in Others

Figure 20. Global Neisseria meningitidis Infections Drug Market: Others (2017-2022) & (K Pcs)

Figure 21. Global Neisseria meningitidis Infections Drug Sales Market Share by Application (2017-2022)

Figure 22. Global Neisseria meningitidis Infections Drug Revenue Market Share by Application in 2021

Figure 23. Neisseria meningitidis Infections Drug Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Neisseria meningitidis Infections Drug Revenue Market Share by Company in 2021

Figure 25. Global Neisseria meningitidis Infections Drug Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Neisseria meningitidis Infections Drug Revenue Market Share by Geographic Region in 2021

Figure 27. Global Neisseria meningitidis Infections Drug Sales Market Share by Region (2017-2022)

Figure 28. Global Neisseria meningitidis Infections Drug Revenue Market Share by Country/Region in 2021

Figure 29. Americas Neisseria meningitidis Infections Drug Sales 2017-2022 (K Pcs)

Figure 30. Americas Neisseria meningitidis Infections Drug Revenue 2017-2022 ($ Millions)

Figure 31. APAC Neisseria meningitidis Infections Drug Sales 2017-2022 (K Pcs)

Figure 32. APAC Neisseria meningitidis Infections Drug Revenue 2017-2022 ($ Millions)

Figure 33. Europe Neisseria meningitidis Infections Drug Sales 2017-2022 (K Pcs)

Figure 34. Europe Neisseria meningitidis Infections Drug Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Neisseria meningitidis Infections Drug Sales 2017-2022 (K Pcs)

Figure 36. Middle East & Africa Neisseria meningitidis Infections Drug Revenue 2017-2022 ($ Millions)

Figure 37. Americas Neisseria meningitidis Infections Drug Sales Market Share by Country in 2021

Figure 38. Americas Neisseria meningitidis Infections Drug Revenue Market Share by Country in 2021

Figure 39. United States Neisseria meningitidis Infections Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Neisseria meningitidis Infections Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Neisseria meningitidis Infections Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Neisseria meningitidis Infections Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Neisseria meningitidis Infections Drug Sales Market Share by Region in 2021

Figure 44. APAC Neisseria meningitidis Infections Drug Revenue Market Share by Regions in 2021

Figure 45. China Neisseria meningitidis Infections Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Neisseria meningitidis Infections Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Neisseria meningitidis Infections Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Neisseria meningitidis Infections Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Neisseria meningitidis Infections Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Neisseria meningitidis Infections Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Neisseria meningitidis Infections Drug Sales Market Share by Country in 2021

Figure 52. Europe Neisseria meningitidis Infections Drug Revenue Market Share by Country in 2021

Figure 53. Germany Neisseria meningitidis Infections Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Neisseria meningitidis Infections Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Neisseria meningitidis Infections Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Neisseria meningitidis Infections Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Neisseria meningitidis Infections Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Neisseria meningitidis Infections Drug Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Neisseria meningitidis Infections Drug Revenue Market Share by Country in 2021

Figure 60. Egypt Neisseria meningitidis Infections Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Neisseria meningitidis Infections Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Neisseria meningitidis Infections Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Neisseria meningitidis Infections Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Neisseria meningitidis Infections Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Neisseria meningitidis Infections Drug in 2021

Figure 66. Manufacturing Process Analysis of Neisseria meningitidis Infections Drug

Figure 67. Industry Chain Structure of Neisseria meningitidis Infections Drug

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles